Thus, while plasma NfL concentration is a sensitive biomarker for acute neurological damage after stroke (noting that tMCAO produces the largest strokes), it is uncertain whether it can reflect ongoing/delayed degeneration and/or if greater assay sensitivity may be needed to detect later degeneration, particularly in the distal MCAO models. This evidence concerns the gene NEFL and stroke disorder.